Skinvisible (SKVI) Net Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Skinvisible (SKVI) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.06 Bn | 626.30 Bn | 17.26 Bn | -146.00 |
| 2 | AbbVie | 440.06 Bn | 433.49 Bn | 12.70 Bn | 1,518.00 |
| 3 | Merck | 364.19 Bn | 357.05 Bn | 12.21 Bn | -3,607.00 |
| 4 | Novartis Ag | 268.45 Bn | 260.76 Bn | 11.24 Bn | -610.00 |
| 5 | Pfizer | 158.40 Bn | 146.70 Bn | 10.94 Bn | -2,157.00 |
| 6 | Sanofi | 52.57 Bn | 45.19 Bn | 10.79 Bn | -3,647.00 |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | - |
| 8 | Incyte | 24.98 Bn | 20.44 Bn | 1.57 Bn | 166.00 |
| 9 | United Therapeutics | 21.15 Bn | 18.49 Bn | 683.80 Mn | 376.00 |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | 46,848.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46,848.00 |
| Mar 31, 2026 | 27,642.00 |
| Dec 31, 2025 | 218,098.00 |
| Sep 30, 2025 | 84,962.00 |
| Jun 30, 2025 | 60,692.00 |
| Mar 31, 2025 | 18,734.00 |
| Dec 31, 2024 | -127,230.00 |
| Sep 30, 2024 | -10,416.00 |
| Jun 30, 2024 | -57,916.00 |
| Mar 31, 2024 | 2.45 Mn |
| Dec 31, 2023 | 210,204.00 |
| Sep 30, 2023 | -125,975.00 |
| Jun 30, 2023 | -550,692.00 |
| Mar 31, 2023 | -2.97 Mn |
| Dec 31, 2022 | -799,528.00 |
| Sep 30, 2022 | -430,810.00 |
| Jun 30, 2022 | -645.00 |
| Mar 31, 2022 | 299,846.00 |
| Dec 31, 2021 | 75,722.00 |
| Sep 30, 2021 | 1.54 Mn |